ARTICLE | Company News
CollaGenex dermatology news
May 23, 2005 7:00 AM UTC
CGPI restructured following the approval of generic versions of the company's Periostat doxycycline periodontitis drug. The company plans to reduce its headcount by 63 people, which will include its ...